Takeda Pharmaceutical Company Limited (TAK) Debt by Year

TAK

Takeda Pharmaceutical Company Limited carried $26.5B in long-term debt against $2.6B in cash and equivalents at the end of fiscal year 2025. Long-term debt fell 10.6% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.

FY2025 annual

Long-Term Debt $26.5B

Cash & Equivalents $2.6B

YoY -10.6%

5Y CAGR -8.8%

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Mar 31, 2025 Reported Jun 25, 2025 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TAK Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	FY2520-F	FY2420-F	FY2320-F	FY2220-F	FY2120-F	FY2020-F	FY1920-F	FY1820-F	FY1720-F
Long-Term Debt	$26.5B-10.6%	$29.6B-2.8%	$30.5B-10.7%	$34.1B-18.2%	$41.7B-0.5%	$41.9B-2.7%	$43.1B+364.0%	$9.3B	N/A
Cash & Equivalents	$2.6B-15.1%	$3.0B-24.7%	$4.0B-42.6%	$7.0B-19.9%	$8.7B+47.3%	$5.9B-6.5%	$6.3B+128.7%	$2.8B-3.3%	$2.9B

TAK Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q4'2520-F	Q4'2420-F	Q4'2320-F	Q4'2220-F	Q4'2120-F	Q4'2020-F	Q4'1920-F	Q4'1820-F
Long-Term Debt	$26.5B-10.6%	$29.6B-2.8%	$30.5B-10.7%	$34.1B-18.2%	$41.7B-0.5%	$41.9B-2.7%	$43.1B+364.0%	$9.3B
Cash & Equivalents	$2.6B-15.1%	$3.0B-24.7%	$4.0B-42.6%	$7.0B-19.9%	$8.7B+47.3%	$5.9B-6.5%	$6.3B+128.7%	$2.8B

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Takeda Pharmaceutical Company Limited financials

Frequently Asked Questions

What was Takeda Pharmaceutical Company Limited's long-term debt in fiscal year 2025?

Takeda Pharmaceutical Company Limited carried $26.5B in long-term debt against $2.6B in cash and equivalents at the end of fiscal year 2025.

How fast is Takeda Pharmaceutical Company Limited's long-term debt growing?

Takeda Pharmaceutical Company Limited (TAK) long-term debt fell by 10.6% year over year, from $29.6B to $26.5B in fiscal year 2025.

What was Takeda Pharmaceutical Company Limited's long-term debt in the most recent quarter?

Takeda Pharmaceutical Company Limited (TAK) reported $26.5B in long-term debt in Q4 2025. This represents a decrease of 10.6% from the same quarter a year earlier.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.